Literature DB >> 1934668

Immunohistological localization of apolipoproteins in the glomeruli in renal disease: specifically apoB and apoE.

H Sato1, S Suzuki, H Kobayashi, S Ogino, A Inomata, M Arakawa.   

Abstract

Recently it has become clear that abnormalities of the lipid metabolism may play a large role in the progression of renal diseases. To investigate the relationship between lipids and kidney tissues, the authors employed an immunofluorescent technique to determine the presence of apolipoprotein (apo) B and E in kidney tissue, particularly the glomeruli, and analyzed the relationship between their deposition and the clinical and histological findings of a total of 49 patients with persistent proteinuria and/or hematuria (age range: 10 to 62 years). The patients were divided into 4 groups, as follows: both apoB and apoE negative cases (Group 1; 17 cases), apoB alone positive (Group 2; 7 cases), apoE alone positive (Group 3; 10 cases) and both apoB and apoE positive cases (Group 4; 15 cases). Group 2 had more severe proteinuria and a higher level of total cholesterol than Group 1. Group 3 exhibited a higher incidence of glomerular adhesion and interstitial changes than Group 1. Group 4, on the other hand, exhibited more severe mesangial hypercellularity and a higher incidence of glomerular sclerosis and interstitial scarrings than Group 1, a higher incidence of glomerular sclerosis than Group 2, more severe proteinuria, higher serum levels of total cholesterol, and lower serum levels of total protein than Groups 1 and 3 and higher level of uric acid than Group 1. These results suggest that the deposition of apoB and apoE accelerates the progression of mesangial lesions, resulting in greater proteinuria and glomerular sclerosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1934668

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  12 in total

1.  Genetic diversity of the apolipoprotein E gene and diabetic nephropathy: a meta-analysis.

Authors:  Yang Li; Kefu Tang; Zhao Zhang; Ming Zhang; Zhen Zeng; Zangdong He; Lin He; Chunling Wan
Journal:  Mol Biol Rep       Date:  2010-02-24       Impact factor: 2.316

2.  Proteoglycans can mediate renal lipoprotein retention.

Authors:  L R Tannock
Journal:  Diabetologia       Date:  2006-03-11       Impact factor: 10.122

3.  Prevention of renal apoB retention is protective against diabetic nephropathy: role of TGF-β inhibition.

Authors:  Patricia G Wilson; Joel C Thompson; Meghan H Yoder; Richard Charnigo; Lisa R Tannock
Journal:  J Lipid Res       Date:  2017-09-14       Impact factor: 5.922

4.  Reversibility of renal injury with cholesterol lowering in hyperlipidemic diabetic mice.

Authors:  Deepa Taneja; Joel Thompson; Patricia Wilson; Katie Brandewie; Liliana Schaefer; Bonnie Mitchell; Lisa R Tannock
Journal:  J Lipid Res       Date:  2010-01-28       Impact factor: 5.922

5.  Pathogenic antibodies inhibit the binding of apolipoproteins to megalin/gp330 in passive Heymann nephritis.

Authors:  D Kerjaschki; M Exner; R Ullrich; M Susani; L K Curtiss; J L Witztum; M G Farquhar; R A Orlando
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

6.  Renal accumulation of biglycan and lipid retention accelerates diabetic nephropathy.

Authors:  Joel Thompson; Patricia Wilson; Katie Brandewie; Deepa Taneja; Liliana Schaefer; Bonnie Mitchell; Lisa R Tannock
Journal:  Am J Pathol       Date:  2011-06-30       Impact factor: 4.307

Review 7.  Soluble biglycan as a biomarker of inflammatory renal diseases.

Authors:  Louise Tzung-Harn Hsieh; Madalina-Viviana Nastase; Jinyang Zeng-Brouwers; Renato V Iozzo; Liliana Schaefer
Journal:  Int J Biochem Cell Biol       Date:  2014-08-01       Impact factor: 5.085

8.  Lycopene ameliorates renal function in rats with streptozotocin-induced diabetes.

Authors:  Wei Li; Guoguang Wang; Xiaohua Lu; Yuxin Jiang; Lei Xu; Xue Zhao
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

9.  The Protective Effects of Cobra Venom from Naja naja atra on Acute and Chronic Nephropathy.

Authors:  Shu-Zhi Wang; He He; Rong Han; Jia-Li Zhu; Jian-Qun Kou; Xiao-Lan Ding; Zheng-Hong Qin
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-25       Impact factor: 2.629

Review 10.  Cholesterol Disturbances and the Role of Proper Nutrition in CKD Patients.

Authors:  Anna Gluba-Brzozka; Beata Franczyk; Jacek Rysz
Journal:  Nutrients       Date:  2019-11-18       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.